Type A dissection and chronic dilatation: Tenascin-C as a key factor in destabilization of the aortic wall

Interactive Cardiovascular and Thoracic Surgery

Volumn 17, Issue 2, 2013, Pages 365-370

  Trescher, Karola ^a,b   Thometich, Barbara ^b   Demyanets, Svitlana ^b   Kassal, Hermann ^a   Sedivy, Roland ^a   Bittner, Reginald ^b   Holzinger, Christoph ^a   Podesser, Bruno K ^a,b  

^a LK St Pölten ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aorta aortic pathology; Aortic aneurysm; Aortic dissection

Indexed keywords

TENASCIN;

ADULT; AGED; AORTA DISSECTION; AORTA TYPE A DISSECTION; AORTA VALVE REPLACEMENT; AORTA WALL DESTABILIZATION; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; ASCENDING AORTA; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SOFTWARE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE;

EID: 84880727785     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivt204     Document Type: Article

References (21)

1. Golledge J, Eagle K. Acute aortic dissection. Lancet 2008;372:55-66.
2. Pape LA, Tsai TT, Isselbacher EM, Oh JK, O'Gara PT, Evangelista A et al. On behalf of the International Registry of Acute Aortic Dissection (IRAD) Investigators. Aortic diameter 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation 2007;116:1120-7.
3. Taketani T, Imai Y, Morota T, Maemura K, Morita H, Hayashi D et al. Altered patterns of gene expression specific to thoracic aortic aneurysms Microarray analysis of surgically resected specimen. Int Heart J 2005;46: 265-77.
4. Tang PCY, Coady MA, Lovoulos C, Dardik A, Aslan M, Elefteriades JA et al. Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms. Circulation 2005;112:1098-105.
5. Jones FS, Jones PL. The tenascin family of ECM glycoproteins: structure, function and regulation during embryogenic development and tissue remodeling. Dev Dyn 2000;218:235-59.
6. Sato A, Aonuma K, Imanaka-Yoshida K, Yoshida T, Isobe M, Kawase D et al. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol 2006;47:2319-25.
7. Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M et al. Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol 2005;167:71-80.
8. Imanaka-Yoshida K, Matsuura R, Isaka N, Nakano T, Sakakura T, Yoshida T. Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: clinical significance of early tenascin-c expression. Virchows Arch 2001;439: 185-90.
9. Yamamoto K, Onoda K, Sawada Y, Fujinaga K, Imanaka-Yoshida K, Shimpo H et al. Tenascin-C is an essential factor for intimal hyperplasia after aortotomy in mice. Cardiovasc Res 2005;65:737-42.
10. Jones PL, Cowan KN, Rabinovitch M. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 1997;150:1349-60.
11. Bouvet C, Gilbert L-A, Girardot D, deBlois D, Moreau P. Different involvement of ECM components in small and large arteries during chronic NO synthase inhibition. Hypertension 2005;45:432-7.
12. Nataatmadja M, West M, Summers K, Walker P, Nagata M, Watanabe T. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 2003;108 (Suppl 1):II329-34.
13. Chiquet-Ehrismann R, Hagios C, Schenk S. The complexity of regulating tenascins. BioEssays 1995;17:873-8.
14. Mackie EJ, Scott-Burden T, Hahn AWA, Kern F, Bernhardt J, Regenass S et al. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol 1992;141: 377-88.
15. Della Corte A, Quarto C, Bancone C, Castaldo C, Di Meglio F, Nurzynska D et al. Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling. J Thorac Cardiovasc Surg 2008;135:8-18.
16. Majumdar R, Miller DV, Ballman KV, Unnikrishnan G, McKellar SH, Sarkar G et al. Elevated expressions of osteopontin and tensacin C in ascending aortic aneurysms are associated with trileaflet aortic valves as compared with bicuspid aortic valves. Cardiovasc Pathol 2007;16: 144-50.
17. Jones PL, Jones FS, Zhou B, Rabinovitch M. Induction of vascular smooth muscle cell tenascin-C gene expression by denatured type I collagen is dependent upon a ?3 integrin-mediated mitogen-activated protein kinase pathway and a 122-base pair promoter element. J Cell Sci 1999; 112:435-45.
18. Thyberg J, Hultgardh-Nilsson A. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res 1994;276:263-71.
19. Kirsch EW, Radu NC, Gervais M, Allaire E, Loisance DY. Heterogeneity in the remodeling of aneurysms of the ascending aorta with tricuspid aortic valves. J Thorac Cardiovasc Surg 2006;132:1010-6.
20. Kimura T, Yoshimura K, Aoki H, Imanaka-Yoshida K, Yoshida T, Ikeda Y et al. Tenascin-C is expressed in abdominal aortic aneurysm tissue with an active degradation process. Pathol Intern 2011;61: 559-64.
21. Imanaka-Yoshida K, Hiroe M, Yasutomi Y, Toyozaki T, Tsuchyia T, Noda N et al. Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol 2002;197:388-94.